Ditazole
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| |
| Ditazole
| |
| Systematic (IUPAC) name | |
| 2,2'-(4,5-diphenyloxazol-2-ylazanediyl)diethanol | |
| Identifiers | |
| CAS number | |
| ATC code | B01 |
| PubChem | |
| Chemical data | |
| Formula | C19H20N2O3 |
| Mol. mass | 324.374 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Ditazole | |
|
Articles | |
|---|---|
|
Most recent articles on Ditazole | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Ditazole at Clinical Trials.gov Clinical Trials on Ditazole at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Ditazole
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Directions to Hospitals Treating Ditazole Risk calculators and risk factors for Ditazole
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Ditazole | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Ditazole is a platelet aggregation inhibitor.It is marketed in Spain and Portugal under the trade name Ageroplas.[1]
References
- ↑ Martindale's Complete Drug Reference,http://www.medicinescomplete.com/mc/martindale/current/2639-d.htm
- The Merck Index, 12th Edition. 3432
WikiDoc Research Resources for Ditazole | |
|---|---|
| Articles on Ditazole | Most recent articles on Ditazole • Most cited articles on Ditazole • Review articles on Ditazole • Articles on Ditazole in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Ditazole | Powerpoint slides on Ditazole • Images of Ditazole • Photos of Ditazole • Podcasts & MP3s on Ditazole • Videos on Ditazole |
| Evidence Based Medicine Regarding Ditazole | Cochrane Collaboration on Ditazole • Bandolier on Ditazole • TRIP on Ditazole |
| Cost Effectiveness of Ditazole | Cost Effectiveness of Ditazole |
| Clinical Trials Involving Ditazole | Ongoing Trials on Ditazole at Clinical Trials.gov • Trial results on Ditazole • Clinical Trials on Ditazole at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Ditazole | US National Guidelines Clearinghouse on Ditazole • NICE Guidance on Ditazole • NHS PRODIGY Guidance • FDA on Ditazole • CDC on Ditazole |
| Textbook Information on Ditazole | Books and Textbook Information on Ditazole |
| Pharmacology Resources on Ditazole | Dosing of Ditazole • Drug interactions with Ditazole • Side effects of Ditazole • Allergic reactions to Ditazole • Overdose information on Ditazole • Carcinogenicity information on Ditazole • Ditazole in pregnancy • Pharmacokinetics of Ditazole • |
| Genetics, Pharmacogenomics, and Proteinomics of Ditazole | Genetics of Ditazole • Pharmacogenomics of Ditazole • Proteomics of Ditazole |
| Newstories on Ditazole | Ditazole in the news • Be alerted to news on Ditazole • News trends on Ditazole |
| Commentary on Ditazole | Blogs on Ditazole |
| Patient Resources on Ditazole | Patient resources on Ditazole • Discussion groups on Ditazole • Patient Handouts on Ditazole • Directions to Hospitals Treating Ditazole • Risk calculators and risk factors for Ditazole |
| Healthcare Provider Resources on Ditazole | Symptoms of Ditazole • Causes & Risk Factors for Ditazole • Diagnostic studies for Ditazole • Treatment of Ditazole |
| Continuing Medical Education (CME) Programs on Ditazole | CME Programs on Ditazole |
| International Resources on Ditazole | Ditazole en Espanol • Ditazole en Francais |
| Business Resources on Ditazole | Ditazole in the Marketplace • Patents on Ditazole |
| Informatics Resources on Ditazole | List of terms related to Ditazole |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
